Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte ActivationGordon J. Freeman, Tasuku Honjo, Andrew J. Long et al.|The Journal of Experimental Medicine|2000Cited by 5.2k
PD-L2 is a second ligand for PD-1 and inhibits T cell activationYvette Latchman, Gordon J. Freeman, Clive R. Wood et al.|Nature Immunology|2001Cited by 2.9k
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen PredictionDaniel K. Wells, Elham Sherafat, Marit M. van Buuren et al.|Cell|2020Cited by 534
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targetingAdham S. Bear, Beatriz M. Carreno|Nature Communications|2021Cited by 111
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer modelsPatrizia Porazzi, Marco Ruella, Kelly Markowitz et al.|Cancer Cell|2025Cited by 47